Literature DB >> 10867330

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

D O Taylor1, R L Yowell, A G Kfoury, E H Hammond, D G Renlund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10867330     DOI： 10.1016/s1053-2498(00)00095-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  15 in total

1.  Cardiac allograft vasculopathy: a complex multifactorial sequela of heart transplantation.

Authors:  Ana Maria Segura; L Maximilian Buja
Journal:  Tex Heart Inst J       Date:  2013

2.  New developments for the detection and treatment of cardiac vasculopathy.

Authors:  Kevin J Clerkin; Ziad A Ali; Donna M Mancini
Journal:  Curr Opin Cardiol       Date:  2017-02-15       Impact factor: 2.161

3.  Letter by Clerkin et al Regarding Article, "Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation".

Authors:  Kevin J Clerkin; Maryjane A Farr; Donna M Mancini
Journal:  Circulation       Date:  2018-04-24       Impact factor: 29.690

4.  Report from a consensus conference on antibody-mediated rejection in heart transplantation.

Authors:  Jon Kobashigawa; Maria G Crespo-Leiro; Stephan M Ensminger; Hermann Reichenspurner; Annalisa Angelini; Gerald Berry; Margaret Burke; Lawrence Czer; Nicola Hiemann; Abdallah G Kfoury; Donna Mancini; Paul Mohacsi; Jignesh Patel; Naveen Pereira; Jeffrey L Platt; Elaine F Reed; Nancy Reinsmoen; E Rene Rodriguez; Marlene L Rose; Stuart D Russell; Randy Starling; Nicole Suciu-Foca; Jose Tallaj; David O Taylor; Adrian Van Bakel; Lori West; Adriana Zeevi; Andreas Zuckermann
Journal:  J Heart Lung Transplant       Date:  2011-03       Impact factor: 10.247

5.  Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.

Authors:  Kevin J Clerkin; Maryjane A Farr; Susan W Restaino; Emmanuel Zorn; Farhana Latif; Elena R Vasilescu; Charles C Marboe; Paolo C Colombo; Donna M Mancini
Journal:  J Heart Lung Transplant       Date:  2016-11-17       Impact factor: 10.247

6.  Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients.

Authors:  William Robert Morrow; Elizabeth A Frazier; William T Mahle; Terry O Harville; Sherry E Pye; Kenneth R Knecht; Emily L Howard; R Neal Smith; Robert L Saylors; Xiomara Garcia; Robert D B Jaquiss; E Steve Woodle
Journal:  Transplantation       Date:  2012-02-15       Impact factor: 4.939

Review 7.  Management of allosensitized cardiac transplant candidates.

Authors:  Mauricio Velez; Maryl R Johnson
Journal:  Transplant Rev (Orlando)       Date:  2009-10       Impact factor: 3.943

Review 8.  Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.

Authors:  Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Expert Rev Clin Immunol       Date:  2012-09       Impact factor: 4.473

Review 9.  Mechanisms of chronic cardiac allograft rejection.

Authors:  John P Costello; Thalachallour Mohanakumar; Dilip S Nath
Journal:  Tex Heart Inst J       Date:  2013

10.  Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.

Authors:  Grace W Wu; Jon A Kobashigawa; Michael C Fishbein; Jignesh K Patel; Michelle M Kittleson; Elaine F Reed; Krista K Kiyosaki; Abbas Ardehali
Journal:  J Heart Lung Transplant       Date:  2009-03-14       Impact factor: 10.247
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.